Results 171 to 180 of about 594,203 (304)

Exploring the Anthelmintic, Antioxidant, and Cytotoxic Potential of Khaya grandifoliola and Faidherbia albida Extract Combinations: In Vitro Studies on Heligmosomoides polygyrus and Caenorhabditis elegans

Journal of Parasitology Research
Yamssi Cédric, Noumedem Anangmo Christelle Nadia, Baigomen Christalin, Mounvera Abdel Azizi, Tako Djimefo Alex Kevin, Vincent Khan Payne, Haibo Hu   +6 more
doaj   +1 more source

Prevention is better than cure for emerging infectious diseases. [PDF]

, 2014
Dar, Osman A, Heymann, David L
core   +1 more source

A broadly applicable split-luciferase biosensor approach for rapid antibody detection in emerging infectious diseases. [PDF]

Appl Microbiol Biotechnol
Li X, Niu Q, Wang J, Chai Y, Zou X, Sun H, Yin H, Dou S, Guan G, Yang J.   +9 more
europepmc   +1 more source

Aptamer‐Based Delivery Systems for VEGF and NGF Modulation in Ocular Therapies

Advanced Healthcare Materials, EarlyView.
Aptamer‐based delivery systems targeting NGF and VEGF hold significant potential for precise and sustained treatment of complex diseases affecting both the anterior and posterior segments of the eye. This review critically summarizes current strategies for NGF and VEGF delivery as well as VEGF sequestration, providing a clinical perspective on how ...
Nadine Best, Gizem Karabiyik, Gerd Geerling, Sarah Barbara Zwingelberg, Gregor Lang, Martin Humenik   +5 more
wiley   +1 more source

Climate change and the global food chain: a catalyst for emerging infectious diseases? [PDF]

Int J Emerg Med
Chandipwisa C, Uwishema O, Debebe A, Abdalmotalib MM, Barakat R, Oumer A, John M, Taa L, Onyeaka H.   +8 more
europepmc   +1 more source

Nanobody‐Conjugated Theranostic Prodrug Targeting αvβ3 Integrin Enables Precision Cancer Therapy With Real‐Time Imaging

Advanced Healthcare Materials, EarlyView.
The image shows a schematic form a nanobody‐conjugated theranostic prodrug (NBD) platform targeting tumor‐associated αvβ3 integrin. The NBD system integrates selective nanobody‐mediated tumor recognition, glutathione‐responsive disulfide cleavage for doxorubicin release, and aza‐BODIPY‐based near‐infrared fluorescence for real‐time imaging.
Sanu Karan, Hyunseung Lee, Rema Naskar, Mi Young Cho, Hye Sun Park, Eun Hee Han, Soumyadip Hore, Sun Hee Cho, Truc Ngoc Kim Lam, Taewoong Son, Tae Jung Park, Inkyu Hwang, Jonathan L. Sessler, Kwan Soo Hong   +13 more
wiley   +1 more source

Promising Vaccine Formulations for Emerging Infectious Diseases. [PDF]

Int J Mol Sci
Park PG, Lee SY, Youn H, Hong KJ.
europepmc   +1 more source

EMERGING INFECTIOUS DISEASES – OVERVIEW

Disease-a-Month, 2018
openaire   +2 more sources

Biomimetic Copper Nanoparticles Coated with ACE2‐Overexpressing Membranes for Selective SARS‐CoV‐2 Neutralization and Disinfection

Advanced Healthcare Materials, EarlyView.
By fusing ACE2‐overexpressing membrane‐integrated liposome (MIL) with copper nanoparticles, the biomimetic Cu@MIL nanostructures were created that directly hijack the SARS‐CoV‐2 entry pathway. These particles combine potent virus‐targeting precision with intrinsic antiviral activity, achieving rapid neutralization and disinfection.
Pooja Aich, Wei‐Pang Chung, Wen‐Jyun Wang, Hidenobu Takahashi, Ming‐Shun Hsieh, Ying‐Chen Lin, Oh Seok Kwon, Wei‐Peng Li, Wei‐Lun Huang   +8 more
wiley   +1 more source

Editorial: Vaccines and therapeutics utilizing new adjuvants and potential inhibitors to target emerging infectious diseases. [PDF]

Front Immunol
Kim J, Jobe O, Broadhurst MJ.
europepmc   +1 more source